A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
While the stock appears to have experienced tremendous revenue growth it really hasn't. 2010 was a horrid year for Biolase as Schein and Biolase were trying to disolver their partnership. Basically niether party was actively selling. True comparisions should be made against FY2009. In the second quarter Biolase had revenues of ~$14 and that was the worst second quarter since 2003.